Acesso livre
Acesso livre

Mastologia

Diretriz NCCN atualizada | Câncer de mama.

21 Jun, 2022 | 12:58h

Breast Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology – Journal of the National Comprehensive Cancer Network


Estudo de coorte | Associação do rastreamento com tomossíntese digital de mama vs. mamografia digital com o risco de câncer de mama avançado e invasivo.

19 Jun, 2022 | 17:12h

Association of Screening With Digital Breast Tomosynthesis vs Digital Mammography With Risk of Interval Invasive and Advanced Breast Cancer – JAMA (gratuito por tempo limitado)

Editorial: Digital Breast Tomosynthesis and Detection of Interval Invasive and Advanced Breast Cancers – JAMA (gratuito por tempo limitado)

Comunicado de imprensa: 3-D Mammography Technique Benefits Some Women, Not All – University of California San Francisco


Breve resumo dos principais fatos atuais e recomendações | Linfadenopatia regional após vacinação contra COVID-19 em pacientes com ou sem suspeita de câncer de mama.

19 Jun, 2022 | 14:21h

Regional Lymphadenopathy Following COVID-19 Vaccination in Patients with or Suspicious of Breast Cancer: A Quick Summary of Current Key Facts and Recommendations – Korean Journal of Radiology

Conteúdos relacionados:

2 Case Series and Guidance | Lymphadenopathy in COVID-19 Vaccine Recipients

Axillary lymphadenopathy at the time of COVID-19 vaccination: ten recommendations from the European Society of Breast Imaging (EUSOBI) – Insights into Imaging

Covid-19: Schedule breast screening before vaccine or 4 to 6 weeks after to avoid false positives, says guidance – The BMJ

Frequency and outcomes of MRI-detected axillary adenopathy following COVID-19 vaccination – European Radiology

Regional lymphadenopathy following COVID-19 vaccination: Literature review and considerations for patient management in breast cancer care – European Journal of Cancer


DNA circulante de tumor e recorrência tardia em câncer de mama de alto risco, positivo para receptor de hormônio e negativo para receptor do fator de crescimento epidérmico humano 2.

19 Jun, 2022 | 13:04h

Circulating Tumor DNA and Late Recurrence in High-Risk Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Breast Cancer – Journal of Clinical Oncology

Editorial: Can a Late Interception by Circulating Tumor DNA Deliver a Win in Estrogen Receptor–Positive Early Breast Cancer?

Comentário: Tumor DNA Assay Portends Metastatic Breast Cancer Recurrence Months in Advance — First evidence for patients in late adjuvant setting, years after initial diagnosis – MedPage Today (necessário cadastro gratuito)

 

Comentário no Twitter

 


Estudo de coorte | Qualidade de vida de longo prazo em pacientes com câncer de mama após conservação da mama vs. mastectomia e reconstrução.

16 Jun, 2022 | 12:47h

Long-term Quality of Life in Patients With Breast Cancer After Breast Conservation vs Mastectomy and Reconstruction – JAMA Surgery (link para o resumo – $ para o texto completo)

Comentários:

Long-Term QOL Examined for Surgical Choices in Breast Cancer – HealthDay

Improved Long-Term Quality-of-Life Measures in Women Undergoing Breast Conservation vs Mastectomy and Reconstruction for Early Breast Cancer – The ASCO Post

 

Comentário no Twitter

 


Estudo randomizado de fase 2 | Eficácia do epigalocatecina-3-galato na prevenção de dermatites em pacientes com câncer de mama sob radioterapia pós-cirúrgica.

6 Jun, 2022 | 11:11h

Efficacy of Epigallocatechin-3-Gallate in Preventing Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy: A Double-Blind, Placebo-Controlled, Phase 2 Randomized Clinical Trial – JAMA Dermatology (gratuito por tempo limitado)

Resumo visual: Efficacy of Epigallocatechin-3-Gallate on Dermatitis in Patients With Breast Cancer Receiving Postoperative Radiotherapy


Estudo randomizado | Efeito da radioterapia em posição supina vs. prona sobre os efeitos cutâneos tóxicos agudos em mulheres com mamas densas.

30 Mai, 2022 | 13:05h

Effect of Supine vs Prone Breast Radiotherapy on Acute Toxic Effects of the Skin Among Women With Large Breast Size: A Randomized Clinical Trial – JAMA Oncology (gratuito por tempo limitado)

Editorial: Prone Whole-Breast Radiotherapy—Better Than Supine? (gratuito por tempo limitado)

 

Comentário no Twitter

 


Posicionamento científico | Implementação de teste para BRCA preventivo e preditivo em pacientes com cânceres de mama, ovário, pâncreas e próstata.

27 Mai, 2022 | 13:29h

Implementation of preventive and predictive BRCA testing in patients with breast, ovarian, pancreatic, and prostate cancer: a position paper of Italian Scientific Societies – ESMO Open


Estudo randomizado | Adição de metformina à terapia padrão não melhora os desfechos em pacientes com câncer de mama.

26 Mai, 2022 | 13:31h

Effect of Metformin vs Placebo on Invasive Disease–Free Survival in Patients With Breast Cancer: The MA.32 Randomized Clinical Trial – JAMA (gratuito por tempo limitado)

Editorial: Who Will Benefit From Metformin? – JAMA Oncology

Comunicado de imprensa: Common diabetes drug not effective against early-stage breast cancer, landmark trial reveals – Lunenfeld-Tanenbaum Research Institute


100 artigos mais citados sobre enhanced recovery after surgery (ERAS).

25 Mai, 2022 | 13:46h

Top 100 Most-Cited Articles on Enhanced Recovery After Surgery: A Bibliometric Analysis and Visualized Study – Frontiers in Surgery

Ver também: Complete List of Enhanced Recovery After Surgery (ERAS) Society Guidelines


Mantenha-se atualizado em sua especialidade

 

Escolha quantas especialidades quiser.